1Q3A
Crystal structure of the catalytic domain of human matrix metalloproteinase 10
Summary for 1Q3A
Entry DOI | 10.2210/pdb1q3a/pdb |
Related | 1BQO 1D5J 1D8F 1G49 1UEA |
Descriptor | Stromelysin-2, ZINC ION, CALCIUM ION, ... (5 entities in total) |
Functional Keywords | mmp-10, metalloproteinase, inhibitors, nngh, stromelysin-2, hydroxamic acid, hydrolase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 3 |
Total formula weight | 57314.74 |
Authors | Calderone, V.,Bertini, I.,Fragai, M.,Luchinat, C.,Mangani, S.,Terni, B. (deposition date: 2003-07-29, release date: 2004-04-06, Last modification date: 2023-08-16) |
Primary citation | Bertini, I.,Calderone, V.,Fragai, M.,Luchinat, C.,Mangani, S.,Terni, B. Crystal structure of the catalytic domain of human matrix metalloproteinase 10. J.Mol.Biol., 336:707-716, 2004 Cited by PubMed Abstract: The catalytic domain of matrix metalloproteinase-10 (MMP-10) has been expressed in Escherichia coli and its crystal structure solved at 2.1 A resolution. The availability of this structure allowed us to critically examine the small differences existing between the catalytic domains of MMP-3 and MMP-10, which show the highest sequence identity among all MMPs. Furthermore, the binding mode of N-isobutyl-N-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (NNGH), which is one of the most known commercial inhibitors of MMPs, is described for the first time. PubMed: 15095982DOI: 10.1016/j.jmb.2003.12.033 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report
